SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-17-010669
Filing Date
2017-11-02
Accepted
2017-11-02 16:02:05
Documents
58
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adms10q09302017.htm 10-Q 1018468
2 EXHIBIT 10.1 catalentex101.htm EX-10.1 237661
3 EXHIBIT 10.2 moehsex102.htm EX-10.2 204620
4 EXHIBIT 31.1 admsq310q2017ex311.htm EX-31.1 14295
5 EXHIBIT 31.2 admsq310q2017ex312.htm EX-31.2 14407
6 EXHIBIT 32.1 admsq310q2017ex321.htm EX-32.1 9289
13 forctrtextinamendedan_image1.jpg GRAPHIC 16512
  Complete submission text file 0001628280-17-010669.txt   4483024

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT adms-20170930.xml EX-101.INS 676047
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20170930.xsd EX-101.SCH 30863
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20170930_cal.xml EX-101.CAL 58150
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20170930_def.xml EX-101.DEF 128867
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20170930_lab.xml EX-101.LAB 411790
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20170930_pre.xml EX-101.PRE 234028
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 171172182
SIC: 2834 Pharmaceutical Preparations